Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor´s Picks
 
 
 
NDRC Abandons Government Pricing Setting, By No Means Letting Go of Control
Chief Editor James Shen offers his regular monthly review of the Chinese healthcare sector with this month's emphasis on the latest drug price reform policy and a range o... (5/22/2015)
   
Bloomburg: Foreign Drugmakers Face Pressure to Lower Prices in China (5/25/2015)
Building Better Clinical Trials In China (5/22/2015)
NDRC Abandons Government Pricing Setting, By No Means Letting Go of Control (5/22/2015)
Hot Topics Affecting China's OTC and Consumer Healthcare Market (5/20/2015)
Review of Chinese Pharma Deals, R&D and Regulatory Developments in Q1/2015 (5/13/2015)
The Pharmaceutical Blacklist in China: A Look Back After One Year (5/7/2015)
Analysis: New Draft Fourth Amendment To The Chinese Patent Law (5/7/2015)
Legal Expert Analysis of the Latest Amendment of the Drug Administration Law of PRC (5/7/2015)
NDRC and MOFCOM Issue 2015 Edition of Foreign Investment Industrial Guidance Catalogue (5/5/2015)
Chinese Pharma: A Global Health Game Changer? (4/28/2015)
SAIC Publishes Landmark Antitrust Regulation for Intellectual Property Rights (4/27/2015)
The Era of Radical Healthcare Cost Containment Has Arrived! (4/23/2015)
Are These the Meaningful Changes at the CFDA We've Been Waiting For? (4/21/2015)
Ali Health Offers a Revolutionary Moment for China's Healthcare Industry (4/13/2015)
Birth of A New Novel Anticancer, Made in China (4/3/2015)
Chinese Pharmaceutical Foreign Trade Up ...  (5/26/2015)
GIBHs New Alzheimer's Drug to Enter Clin...  (5/25/2015)
Chunyu Yisheng Lines Up with UCAS for Re...  (5/25/2015)
Moberg Pharma, Menarini AP Launch Kerasa...  (5/22/2015) (free)
Upcoming Event: Finance for Non-Finance ...  (5/22/2015) (free)
Upcoming Event: KAM in Pharma 3.0 Semina...  (5/22/2015) (free)
Hot Topics at Recent PAC Drug Price Refo...  (5/22/2015)
WuXi Launches e-Commerce Platform for Ch...  (5/21/2015) (free)
Chinese Consortium Buys US Biotech Firm ...  (5/21/2015)
MabSpace Bio, Genor Bio Enter Collaborat...  (5/21/2015)
TCM Herb Found To Be Effective Against O...  (5/21/2015)
CAS Scientists to Initiate Clinical Tria...  (5/21/2015)
12 Domestically-listed Pharma Companies ...  (5/20/2015)
CFDA Official Reveals Progress on Amendm...  (5/20/2015)
CFDA Approves Trial of Electronic Regula...  (5/19/2015)
Teva Offers to Buy Mylan for $40.1 Billion
Global Strategic Partners Merck and Pfizer Finalize Agre...
Sun Pharma-Ranbaxy Merger Completed Finally
Actavis Closes Allergan Acquisition
Pfizer to Buy Hospira for US$15 Billion
Chinese Pharmaceutical Foreign Trade Up 7.8 in Q1/2015
SMEI: Chinese Hospital Drug Consumption Up 12.4% in 2014
IMS: Chinese Hospital Drug Sales Up 11.6% in 2014
Nicholas Hall Reports 8% Growth for Chinese OTC VMS Market in 2...
Hospital Oncology Drug Consumption of Six Cities in Yangtze Riv...
Moberg Pharma, Menarini AP Launch Kerasal Nail in China
WuXi Launches e-Commerce Platform for Chemistry Products
Chinese Consortium Buys US Biotech Firm Ambrx
MabSpace Bio, Genor Bio Enter Collaborative R&D Deal for...
12 Domestically-listed Pharma Companies with over CNY 10B in...
Hot Topics at Recent PAC Drug Price Reform Symposium
CFDA Official Reveals Progress on Amendment of Drug Admi...
CFDA Approves Trial of Electronic Regulatory Coding of I...
CFDA to Combine Pharmaceutical Manufacturer License and ...
NHFPC to Issue A New Regulation for Internet Healthcare ...
China Passes Amendment to Advertising Law with Stringent Req...
SAIC Investigates Simens and Two Other Medical Device MNCs O...
VellPharm Wins Lawsuit Against CFDA over Registration Proced...
USTR Releases 2014 Report on China's WTO Compliance Highligh...
China Makes Pledges on Pharma Business, Enforcement and IP a...
USFDA Warns Chinese API Manufacturer Over Manufacturing ...
Tonghua Dongbao Pharma to Build $60M API Plant
UniTao Pharma Suspends Plan for Virgina API Plant
EU Withdraws GMP Certification of NCPC Subsidiary
USFDA Issues Warning Letter to Chinese API Producer Nova...
GIBHs New Alzheimer's Drug to Enter Clinical Trials
TCM Herb Found To Be Effective Against Obesity
CAS Scientists to Initiate Clinical Trials of New Drug f...
Chinese and Australian Scientists Make Breakthrough with...
NHFPC Announces 21 Domestic New Drugs Recommended for Pr...
Chunyu Yisheng Lines Up with UCAS for Research of Health...
State Council Releases New Policy for Urban Public Hospi...
Breast Cancer Treatment Scarce and Outdated in China
Suzhou Launches Full Scale Healthcare and Public Hospita...
State Council Issues New Policy Document Highlighting He...
At Least Four MNCs to Reshuffle Their China GMs in May/Jun...
Former NHFPC Senior Official Investigated for Corruption
Recent Executive Moves
Hospital Director in Yunnan Probed for Bribes of CNY 35M a...
27 Biopharma Billionaires on the 2015 Forbes China Rich Li...
Upcoming Event: Finance for Non-Finance Professionals by...
Upcoming Event: KAM in Pharma 3.0 Seminar by Hanno Wolfr...
Upcoming Event: Innovation Days 2015
Upcoming Event: KAM in Pharma 3.0 Seminar by Hanno Wolfr...
Upcoming Event: Finance for Non-Finance Professionals by...
Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...
WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...
  WiCON Officially Publishes Chi...
  WiCON Officially Publishes Its...
  WiCON Publishes China Pharmace...
  WiCON officially publishes Chi...
  Pharma China adds one more dis...
© Wicon International Group  Support by: www.heightow.com Site map | Contact Us | Links